The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Inflammation and therapeutic vaccination in CNS diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Self-citationPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Wucherpfennig, K. W., & Strominger, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90348-8 · Cited by 1,534
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
Lehmann, P. V., Forsthuber, T., Miller, A., & Sercarz, E. E. (1992) · Nature · doi:10.1038/358155a0 · Cited by 1,186
Regulatory T cells in the control of immune pathology
Maloy, K. J., & Powrie, F. (2001) · Nature Immunology · doi:10.1038/ni0901-816 · Cited by 1,175
Exacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071 · cited 1×
“First, it has been shown directly by the effects of β-interferon, the prototypic T H 1 cytokine, which when administered to individuals with MS caused clinical exacerbation”
BackgroundSørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5150 · Cited by 1,002
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
Moalem, G., Leibowitz–Amit, R., Yoles, E., Mor, F., Cohen, I. R., & Schwartz, M. (1999) · Nature Medicine · doi:10.1038/4734 · Cited by 889
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858 · cited 1×
“Notably, a single parenteral administration of a monoclonal antibody against Aβ has been shown to produce rapid (within hours) benefits on certain behavioural measures of cognitive function in a mouse model, apparently by interfering with some diffusible, putatively synaptotoxic form of Aβ (for example, Aβ oligomers)…”
BackgroundBalashov, K. E., Rottman, J. B., Weiner, H. L., & Hancock, W. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6873 · Cited by 849
Self-citationInduction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells
Weiner, H. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820117.x · Cited by 846
Self-citationThe influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., et al. (2001) · Science · doi:10.1126/science.1062960 · Cited by 829 · cited 1×
“In addition to IL-12, it has been shown recently that osteopontin is important in T H 1 differentiation in autoimmune demyelinating diseas”
BackgroundBielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 763
THE INFLUENCE OF THE PROINFLAMMATORY CYTOKINE, OSTEOPONTIN, ON AUTOIMMUNE DEMYELINATING DISEASE
Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., et al. (2002) · 3rd International Conference on Osteopontin and SIBLING (Small Integrin-Binding Ligand, N-linked Glycoprotein) Proteins, 2002 · doi:10.1100/tsw.2002.326 · Cited by 729
CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS
SIBLEY, W. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92801-6 · Cited by 594
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587
The role of magnetic resonance techniques in understanding and managing multiple sclerosis
Miller, D. (1998) · Brain · doi:10.1093/brain/121.1.3 · Cited by 556
Zhang, J., Markovic-Plese, S., Lacet, B., Raus, J., Weiner, H. L., & Hafler, D. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.973 · Cited by 529
Self-citationKappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Comi, G., Kappos, L., Oger, J., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512
Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L., & Hafler, D. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1985 · Cited by 463
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446 · cited 1×
“Studies of transgenic mice that overexpress an AD-causing mutant form of human amyloid precursor protein (APP) and develop amyloid deposits have shown, however, that crossing such mice with mice overexpressing a natural inhibitor of complement C3 results in a worsening of Aβ plaque load and more neuronal los”
BackgroundAntigen-driven bystander suppression after oral administration of antigens.
Miller, A., Lider, O., & Weiner, H. L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.791 · Cited by 429
Self-citationLafaille, J. J., Keere, F. V. D., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., & Tonegawa, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.307 · Cited by 426
Edan, G., Miller, D., Clanet, M., Confavreux, C., Lyon-Caen, O., Lubetzki, C., Brochet, B., Berry, I., Rolland, Y., Froment, J. C., et al. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.2.112 · Cited by 425
McLaurin, J., Cecal, R., Kierstead, M. E., Tian, X., Phinney, A. L., Manea, M., French, J. E., Lambermon, M. H. L., Darabie, A. A., Brown, M. E., et al. (2002) · Nature Medicine · doi:10.1038/nm790 · Cited by 412
Hiscock, C., & ISDALE, I. C. (1964) · PubMed · Cited by 370
Olsson, T., Zhi, W. W., Höjeberg, B., Kostulas, V, Jiang, Y. P., Anderson, G., Ekre, H. P., & Link, H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114800 · Cited by 368
The importance of inflammatory mechanisms in alzheimer disease
McGeer, E. G., & McGeer, P. L. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00013-8 · Cited by 335
Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 320
Self-citationWeiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C., Issazadeh‐Navikas, S., Hancock, W. W., & Selkoe, D. J. (2000) · PubMed · Cited by 310
Self-citationWeiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C., Issazadeh, S., Hancock, W. W., & Selkoe, D. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<567::aid-ana3>3.0.co;2-w · Cited by 263
Self-citationCuzner, M. L., Gveric, D., Strand, C., Loughlin, A. J., Paemen, L., Opdenakker, G., & Newcombe, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199612000-00002 · Cited by 251
Mechanisms of action of glatiramer acetate in multiple sclerosis
Neuhaus, O., Farina, C., Wekerle, H., & Hohlfeld, R. (2001) · Neurology · doi:10.1212/wnl.56.6.702 · Cited by 248
Comabella, M., Balashov, K., Issazadeh, S., Smith, D., Weiner, H. L., & Khoury, S. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3125 · Cited by 221
Self-citationJansson, M., Panoutsakopoulou, V., Baker, J., Klein, L., & Cantor, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2096 · Cited by 169
Handbook of Multiple Sclerosis
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-7-583_3 · Cited by 167
Monsonego, A., Maron, R., Zota, V., Selkoe, D. J., & Weiner, H. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191118298 · Cited by 161
Self-citationMicroglia, Scavenger Receptors, and the Pathogenesis of Alzheimer’s Disease
El Khoury, J., Hickman, S. E., Thomas, C. A., Loike, J. D., & Silverstein, S. C. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00036-0 · Cited by 159
Weiner, H. L., & Cohen, J. A. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms790oa · Cited by 158
Self-citationBecker, K. J., McCarron, R. M., Ruetzler, C. A., Laban, O., Sternberg, E. M., Flanders, K. C., & Hallenbeck, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10873 · Cited by 153
Linington, C., Engelhardt, B., Kapócs, G., & Lassman, H. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90136-9 · Cited by 145
Garren, H., Ruiz, P. J., Watkins, T. A., da Fontoura, P. P., Nguyen, L.-V. T., Estline, E. R., Hirschberg, D. L., & Steinman, L. (2001) · Immunity · doi:10.1016/s1074-7613(01)00171-6 · Cited by 137
Medaer, R., Stinissen, P., Raus, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91622-9 · Cited by 122
Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice
Furlan, R., Brambilla, E., Sanvito, F., Roccatagliata, L., Olivieri, S., Bergami, A., Pluchino, S., Uccelli, A., Comi, G., & Martino, G. (2003) · Brain · doi:10.1093/brain/awg031 · Cited by 116
Wildbaum, G., Netzer, N., & Karin, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5885 · Cited by 111
MULTIPLE SCLEROSIS: PATHOLOGY, DIAGNOSIS AND MANAGEMENT
Hammond, S. R. (1984) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1984.tb03593.x · Cited by 110
Trieb, K., Ransmayr, G. N., Sgonc, R., Lassmann, H., & Grubeck-Loebenstein, B. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00068-1 · Cited by 106
Karni, A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00018-8 · Cited by 95
Weiner, H. L., Guttmann, C. R. G., Khoury, S. J., Orav, E. J., Hohol, M. J., Kikinis, R., & Jolesz, F. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00273-8 · Cited by 78
Self-citationMaron, R., Hancock, W. W., Slavin, A., Hattori, M., Kuchroo, V. K., & Weiner, H. L. (1999) · International Immunology · doi:10.1093/intimm/11.9.1573 · Cited by 70
Self-citationWildbaum, G., Westermann, J., Maor, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8759 · Cited by 69
Multiple Sclerosis. Pathology, Diagnosis and Management.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-1-144_2 · Cited by 66
Makhlouf, K., Weiner, H. L., & Khoury, S. J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00371-x · Cited by 58
Self-citationTCR Peptide Therapy in Human Autoimmune Diseases
Vandenbark, A. A., Morgan, E. E., Bartholomew, R. M., BOURDETTE, D. N., Whitham, R. H., Carlo, D. J., Gold, D. P., Hashim, G. A., & Offner, H. (2001) · Neurochemical Research · doi:10.1023/a:1010951706830 · Cited by 52
Key issues in Alzheimer's disease inflammation
Cooper, N. R. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00148-2 · Cited by 36
Handbook of Multiple Sclerosis
Cook, S. D. (2001) · CRC Press eBooks · doi:10.1201/9780824741846 · Cited by 32
A 21 Point Unifying Hypothesis on the Etiology and Treatment of Multiple Sclerosis
Weiner, H. L. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100033680 · Cited by 31
Self-citationMonsonego, A., & Weiner, H. L. (2003) · Springer eBooks · doi:10.1007/978-3-642-59332-1_1 · Cited by 1
Self-citation
Cited by
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease
Hock, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., Müller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00294-0 · Cited by 777
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732
Metadata
- Authors
- Weiner, H. L., & Selkoe, D. J.
- Venue
- Nature
- Published
- 2002-12-19
- Volume
- 420
- Issue
- 6917
- Pages
- 879-884
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2040389158
- Cited by
- 255
- References
- 68
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.